Imatinib mesylate‐induced neutrophilic folliculitis in a teenager
2012; Wiley; Volume: 51; Issue: 12 Linguagem: Inglês
10.1111/j.1365-4632.2010.04774.x
ISSN1365-4632
AutoresMaria Teresa García‐Romero, Carola Durán‐McKinster, Marimar Sáez de Ocariz, Daniel Carrasco‐Daza, Carolina Palacios‐López, Luz Orozco‐Covarrubias, Ramón Ruiz‐Maldonado,
Tópico(s)Cutaneous lymphoproliferative disorders research
ResumoInternational Journal of DermatologyVolume 51, Issue 12 p. 1529-1530 Correspondence Imatinib mesylate-induced neutrophilic folliculitis in a teenager Maria Teresa García-Romero MD, Maria Teresa García-Romero MD Hospital General Dr Manuel Gea González, Mexico City, and National Institute of Pediatrics, Mexico City, MexicoSearch for more papers by this authorCarola Durán-McKinster MD, Carola Durán-McKinster MD Hospital General Dr Manuel Gea González, Mexico City, and National Institute of Pediatrics, Mexico City, MexicoSearch for more papers by this authorMarimar Sáez de Ocariz MD, Marimar Sáez de Ocariz MD Hospital General Dr Manuel Gea González, Mexico City, and National Institute of Pediatrics, Mexico City, MexicoSearch for more papers by this authorDaniel Carrasco-Daza MD, Daniel Carrasco-Daza MD Hospital General Dr Manuel Gea González, Mexico City, and National Institute of Pediatrics, Mexico City, MexicoSearch for more papers by this authorCarolina Palacios-López MD, Carolina Palacios-López MD Hospital General Dr Manuel Gea González, Mexico City, and National Institute of Pediatrics, Mexico City, MexicoSearch for more papers by this authorLuz Orozco-Covarrubias MD, Luz Orozco-Covarrubias MD Hospital General Dr Manuel Gea González, Mexico City, and National Institute of Pediatrics, Mexico City, MexicoSearch for more papers by this authorRamón Ruiz-Maldonado MD, Ramón Ruiz-Maldonado MD Hospital General Dr Manuel Gea González, Mexico City, and National Institute of Pediatrics, Mexico City, MexicoSearch for more papers by this author Maria Teresa García-Romero MD, Maria Teresa García-Romero MD Hospital General Dr Manuel Gea González, Mexico City, and National Institute of Pediatrics, Mexico City, MexicoSearch for more papers by this authorCarola Durán-McKinster MD, Carola Durán-McKinster MD Hospital General Dr Manuel Gea González, Mexico City, and National Institute of Pediatrics, Mexico City, MexicoSearch for more papers by this authorMarimar Sáez de Ocariz MD, Marimar Sáez de Ocariz MD Hospital General Dr Manuel Gea González, Mexico City, and National Institute of Pediatrics, Mexico City, MexicoSearch for more papers by this authorDaniel Carrasco-Daza MD, Daniel Carrasco-Daza MD Hospital General Dr Manuel Gea González, Mexico City, and National Institute of Pediatrics, Mexico City, MexicoSearch for more papers by this authorCarolina Palacios-López MD, Carolina Palacios-López MD Hospital General Dr Manuel Gea González, Mexico City, and National Institute of Pediatrics, Mexico City, MexicoSearch for more papers by this authorLuz Orozco-Covarrubias MD, Luz Orozco-Covarrubias MD Hospital General Dr Manuel Gea González, Mexico City, and National Institute of Pediatrics, Mexico City, MexicoSearch for more papers by this authorRamón Ruiz-Maldonado MD, Ramón Ruiz-Maldonado MD Hospital General Dr Manuel Gea González, Mexico City, and National Institute of Pediatrics, Mexico City, MexicoSearch for more papers by this author First published: 09 April 2012 https://doi.org/10.1111/j.1365-4632.2010.04774.xCitations: 4 Ramón Ruiz-Maldonado, MD National Institute of Pediatrics Insurgentes Sur 3700 C Insurgentes Cuicuilco Mexico City 04530 Mexico E-mail: [email protected] We have no conflict of interest whatsoever to report with this publication. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Scheinfeld N. Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate. J Drugs Dermatol 2006; 5: 228–231. 2 Ayirookuzhi SJ, Ramshesh P, Mills G. Imatinib-induced Sweet syndrome in a patient with chronic myeloid leukemia. Arch Dermatol 2005; 141: 368–370. 3 Scheinfeld N. A comprehensive review of imatinib mesylate (Gleevec) for dermatological diseases. J Drugs Dermatol 2006; 5: 117–122. 4 VanoGalvan S, Fernandez-Guarino M, Henriquez-Santana A, et al. Imatinib-induced erythroderma mediated by an unusual non-dose-dependent mechanism. Eur J Dermatol 2007; 17: 538–539. 5 Wahiduzzaman M, Pubalan M. Oral and cutaneous lichenoid reaction with nail changes secondary to imatinib: report of a case and literature review. Dermatol Online J 2008; 14: 14. 6 Alexandrescu DR, Dasanu CA, Farzanmehr H, et al. Persistent cutaneous hyperpigmentation after tyrosine kinase inhibition with imatinib for GIST. Dermatol Online J 2008; 14: 7. 7 Brazzeli V, Roveda E, Prestinari F, et al. Vitiligo-like lesions and diffuse lightening of the skin in a pediatric patient treated with imatinib mesylate: a noninvasive colorimetric assessment. Pediatr Dermatol 2006; 23: 175–178. 8 Dib EG, Ifthikharuddin JJ, Scott GA, et al. Neutrophilic eccrine hidradenitis induced by imatinib mesylate therapy. Leuk Res 2005; 29: 233–234. 9 Ugurel S, Lahaye T, Hildenbrand R, et al. Panniculitis in a patient with chronic myelogenous leukaemia treated with imatinib. Br J Dermatol 2003; 149: 678–679. 10 Heidary N, Naik H, Burgin S. Chemotherapeutic agents and the skin: an update. J Am Acad Dermatol 2008; 58: 545–570. Citing Literature Volume51, Issue12December 2012Pages 1529-1530 ReferencesRelatedInformation
Referência(s)